Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Al-Kaisi F, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Eyre TA, Bygrave C, Kothari J, Basu S, Ramasamy K. Djebbari F, et al. Br J Haematol. 2023 Apr;201(1):162-167. doi: 10.1111/bjh.18672. Epub 2023 Jan 31. Br J Haematol. 2023. PMID: 36720464 No abstract available.
Treat or palliate: outcomes of very elderly myeloma patients.
Panitsas F, Kothari J, Vallance G, Djebbari F, Ferguson L, Sultanova M, Ramasamy K. Panitsas F, et al. Among authors: djebbari f. Haematologica. 2018 Jan;103(1):e32-e34. doi: 10.3324/haematol.2017.173617. Epub 2017 Oct 12. Haematologica. 2018. PMID: 29025911 Free PMC article. No abstract available.
Clinical outcomes of bortezomib-based therapy in myeloma.
Djebbari F, Srinivasan A, Vallance G, Moore S, Kothari J, Ramasamy K. Djebbari F, et al. PLoS One. 2018 Dec 12;13(12):e0208920. doi: 10.1371/journal.pone.0208920. eCollection 2018. PLoS One. 2018. PMID: 30540831 Free PMC article.
Long term outcomes in monoclonal gammopathy of renal significance.
Khera A, Panitsas F, Djebbari F, Kimberger K, Stern S, Quinn J, Rabin N, Kothari J, Alchi B, Haynes R, Winearls C, Roberts I, Ramasamy K. Khera A, et al. Among authors: djebbari f. Br J Haematol. 2019 Sep;186(5):706-716. doi: 10.1111/bjh.15987. Epub 2019 May 29. Br J Haematol. 2019. PMID: 31141168 Free article.
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma.
Djebbari F, Browning JA, Stanton L, Booth S, Hildyard C, Willan J, Bosworth J, Vora SM, Hatton CSR, Collins GP, Eyre TA. Djebbari F, et al. Br J Haematol. 2019 Sep;186(6):e191-e195. doi: 10.1111/bjh.16071. Epub 2019 Jun 20. Br J Haematol. 2019. PMID: 31222716 Free article. Clinical Trial. No abstract available.
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma.
Sharpley FA, Djebbari F, Fourali S, Kothari J, Lynes JA, McLain-Smith S, Ramasamy K. Sharpley FA, et al. Among authors: djebbari f. Leuk Lymphoma. 2020 Mar;61(3):732-736. doi: 10.1080/10428194.2019.1683737. Epub 2019 Nov 27. Leuk Lymphoma. 2020. PMID: 31771382 No abstract available.
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.
Djebbari F, Hubenov H, Neelakantan P, Wolf J, Offer M, Khera A, Louka E, Vallance G, Kothari J, Moore S, Ramasamy K. Djebbari F, et al. Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2. Br J Haematol. 2020. PMID: 31792927 Free article. Clinical Trial. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 31919073
28 results